Compare Quest Diagnostics Inc (DGX) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Prudential Financial Inc — how do they compare? Quest Diagnostics Inc trades at $231.03 (market cap $25.48B), while Prudential Financial Inc trades at $112.83 (market cap $39.17B). The key difference: Prudential Financial Inc is the larger of the two by market cap, and Prudential Financial Inc pays the higher dividend (4.93%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Prudential Financial Inc for 145 Days on average.
| DGX | PRU | |
|---|---|---|
Market Cap | $25.48B | $39.17B |
Volume | 941,866 | 1,436,917 |
Sector | Health | Financials |
52-Week High | $247.45 | $125.13 |
52-Week Low | $173.49 | $92.00 |
Typical Hold Time | 56 Days | 145 Days |
Enterprise Value | $31.23B | $67.95B |
Dividend Yield | 1.49% | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $227.00, down 0.64% with a bearish technical signal. The company shows strong fundamentals with three consecutive quarterly earnings beats and revenue growth from $9.9B in 2024 to $11.0B in 2025. Recent developments include positive clinical study results and a new Apple Health integration, though Medicare reimbursement cuts pose headwinds. The stock trades near support at $226 with oversold RSI readings suggesting potential for near-term bounce.
DGX presents a mixed outlook with solid execution offset by regulatory risks. The 10% upside to consensus price target of $250 offers opportunity, but Medicare payment reductions and rising debt levels require monitoring. Recent earnings momentum and strategic partnerships support growth, making DGX suitable for investors comfortable with healthcare sector volatility.
Prudential Financial (PRU) trades at $112.36, down 1.04% with bearish technical signals despite recent earnings beats. The stock shows attractive valuation metrics with P/E of 10.29 and P/S of 0.61, while maintaining solid profitability with 6.04% net margin and 12.46% ROE. Recent strategic moves include exiting emerging markets with Alexforbes sale and rebranding to Prudential Wealth Advisors, reflecting focus on core operations.
While valuation appears compelling and higher interest rates benefit investment income, analyst sentiment remains cautious with 67.57% hold ratings. The stock faces execution risks from strategic restructuring and competitive pressures in insurance markets. Current price near consensus target of $105.67 suggests limited near-term upside despite fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
